Macular Degeneration Treatment Market: Global Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2017 to 2021 and Forecast 2022 to 2028

$ PRICE - $ 3,000.00$ 8,900.00

Macular Degeneration Treatment Market: By Type (Wet AMD, Dry AMD), By Stage of Disease (Early-stage AMD, Intermediate AMD, Late-stage AMD), By Route of Administration (Intravenous Route, Intravitreal Route), By Distribution Channel (Hospitals, Ophthalmic Clinics, Ambulatory Surgical Centers) and Geography

 

$ PRICE - $ 3,000.00$ 8,900.00
Clear selection
Clear
$ PRICE - $ 3,000.00$ 8,900.00
FacebookTwitterLinkedinEmail
SKU: N/A Category:

Report

Description

1. Executive Summary
2. Global Macular Degeneration Treatment Market Introduction
2.1. Global Macular Degeneration Treatment Market – Taxonomy
2.2. Global Macular Degeneration Treatment Market –Definitions
2.2.1. By Type
2.2.2. By Stage of Disease
2.2.3. By Route of Administration
2.2.4. By Distribution Channel
2.2.5. By Region
3. Global Macular Degeneration Treatment Market Dynamics
3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Trends
3.5. Global Macular Degeneration Treatment Market Dynamic Factors – Impact Analysis
3.6. Global Macular Degeneration Treatment Market – Competition Landscape
4. Global Macular Degeneration Treatment Market Analysis, 2017-2021 and Forecast, 2022-2028
4.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
4.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
4.3. Market Opportunity Analysis
5. Global Macular Degeneration Treatment Market, By Type, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
5.1. Wet AMD
5.1.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
5.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.1.3. Market Opportunity Analysis
5.2. Dry AMD
5.2.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
5.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.2.3. Market Opportunity Analysis
6. Global Macular Degeneration Treatment Market, By Stage of Disease, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
6.1. Early-stage AMD
6.1.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
6.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.1.3. Market Opportunity Analysis
6.2. Intermediate AMD
6.2.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
6.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.2.3. Market Opportunity Analysis
6.3. Late-stage AMD
6.3.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
6.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.3.3. Market Opportunity Analysis
7. Global Macular Degeneration Treatment Market, By Route of Administration, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
7.1. Intravenous Route
7.1.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
7.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.1.3. Market Opportunity Analysis
7.2. Intravitreal Route
7.2.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
7.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.2.3. Market Opportunity Analysis
8. Global Macular Degeneration Treatment Market, By Distribution Channel, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
8.1. Hospitals
8.1.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
8.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.1.3. Market Opportunity Analysis
8.2. Ophthalmic Clinics
8.2.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
8.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.2.3. Market Opportunity Analysis
8.3. Ambulatory Surgical Centers
8.3.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
8.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.3.3. Market Opportunity Analysis
9. Global Macular Degeneration Treatment Market Forecast, By Region, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
9.1. North America
9.1.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
9.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
9.1.3. Market Opportunity Analysis
9.2. Europe
9.2.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
9.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
9.2.3. Market Opportunity Analysis
9.3. Asia-Pacific
9.3.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
9.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
9.3.3. Market Opportunity Analysis
9.4. Latin America
9.4.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
9.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
9.4.3. Market Opportunity Analysis
9.5. Middle East and Africa
9.5.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
9.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
9.5.3. Market Opportunity Analysis
9.6. Global Macular Degeneration Treatment Market – Opportunity Analysis Index, By Type, By Stage of Disease, By Route of Administration, By Distribution Channel, and Region, 2022-2028
10. North America Macular Degeneration Treatment Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
10.1. Type Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
10.1.1. Wet AMD
10.1.2. Dry AMD
10.2. Stage of Disease Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
10.2.1. Early-stage AMD
10.2.2. Intermediate AMD
10.2.3. Late-stage AMD
10.3. Route of Administration Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
10.3.1. Intravenous Route
10.3.2. Intravitreal Route
10.4. Distribution Channel Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
10.4.1. Hospitals
10.4.2. Ophthalmic Clinics
10.4.3. Ambulatory Surgical Centers
10.5. Country Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
10.5.1. USA
10.5.2. Canada
10.6. North America Macular Degeneration Treatment Market – Opportunity Analysis Index, By Type, By Stage of Disease, By Route of Administration, By Distribution Channel, and Country, 2022-2028
10.7. North America Macular Degeneration Treatment Market Dynamics – Trends
11. Europe Macular Degeneration Treatment Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
11.1. Type Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
11.1.1. Wet AMD
11.1.2. Dry AMD
11.2. Stage of Disease Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
11.2.1. Early-stage AMD
11.2.2. Intermediate AMD
11.2.3. Late-stage AMD
11.3. Route of Administration Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
11.3.1. Intravenous Route
11.3.2. Intravitreal Route
11.4. Distribution Channel Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
11.4.1. Hospitals
11.4.2. Ophthalmic Clinics
11.4.3. Ambulatory Surgical Centers
11.5. Country Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
11.5.1. Germany
11.5.2. UK
11.5.3. France
11.5.4. Spain
11.5.5. Italy
11.5.6. Russia
11.5.7. Rest of Europe
11.6. Europe Macular Degeneration Treatment Market – Opportunity Analysis Index, By Type, By Stage of Disease, By Route of Administration, By Distribution Channel, and Country, 2022-2028
11.7. Europe Macular Degeneration Treatment Market Dynamics – Trends
12. Asia-Pacific Macular Degeneration Treatment Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
12.1. Type Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
12.1.1. Wet AMD
12.1.2. Dry AMD
12.2. Stage of Disease Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
12.2.1. Early-stage AMD
12.2.2. Intermediate AMD
12.2.3. Late-stage AMD
12.3. Route of Administration Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
12.3.1. Intravenous Route
12.3.2. Intravitreal Route
12.4. Distribution Channel Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
12.4.1. Hospitals
12.4.2. Ophthalmic Clinics
12.4.3. Ambulatory Surgical Centers
12.5. Country Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
12.5.1. China
12.5.2. India
12.5.3. Japan
12.5.4. ASEAN
12.5.5. Australia & New Zealand
12.5.6. Rest of Asia-Pacific
12.6. Asia-Pacific Macular Degeneration Treatment Market – Opportunity Analysis Index, By Type, By Stage of Disease, by Drug Class, By Distribution Channel, and Country, 2022-2028
12.7. Asia-Pacific Macular Degeneration Treatment Market Dynamics – Trends
13. Latin America Macular Degeneration Treatment Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
13.1. Type Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
13.1.1. Wet AMD
13.1.2. Dry AMD
13.2. Stage of Disease Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
13.2.1. Early-stage AMD
13.2.2. Intermediate AMD
13.2.3. Late-stage AMD
13.3. Route of Administration Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
13.3.1. Intravenous Route
13.3.2. Intravitreal Route
13.4. Distribution Channel Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
13.4.1. Hospitals
13.4.2. Ophthalmic Clinics
13.4.3. Ambulatory Surgical Centers
13.5. Country Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
13.5.1. Brazil
13.5.2. Mexico
13.5.3. Rest of Latin America
13.6. Latin America Macular Degeneration Treatment Market – Opportunity Analysis Index, By Type, By Stage of Disease, By Route of Administration, By Distribution Channel, and Country, 2022-2028
13.7. Latin America Macular Degeneration Treatment Market Dynamics – Trends
14. Middle East and Africa Macular Degeneration Treatment Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
14.1. Type Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
14.1.1. Wet AMD
14.1.2. Dry AMD
14.2. Stage of Disease Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
14.2.1. Early-stage AMD
14.2.2. Intermediate AMD
14.2.3. Late-stage AMD
14.3. Route of Administration Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
14.3.1. Intravenous Route
14.3.2. Intravitreal Route
14.4. Distribution Channel Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
14.4.1. Hospitals
14.4.2. Ophthalmic Clinics
14.4.3. Ambulatory Surgical Centers
14.5. Country Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
14.5.1. Gulf CoDistribution Channel  Council (GCC) Countries
14.5.2. South Africa
14.5.3. Rest of MEA
14.6. MEA Macular Degeneration Treatment Market – Opportunity Analysis Index, By Type, By Stage of Disease, By Route of Administration, By Distribution Channel, and Country, 2022-2028
14.7. MEA Macular Degeneration Treatment Market Dynamics – Trends
15. Competition Landscape 
15.1. Strategic Dashboard of Top Market Players
15.2. Company Profiles (Introduction, Financial Analysis, Key Products, Key Developments, Strategies, and SWOT Analysis)
15.2.1. Hoffmann-La Roche Ltd
15.2.2. Novartis AG
15.2.3. Pfizer
15.2.4. Kanghong Pharma
15.2.5. Bausch Health Companies Inc.
15.2.6. Bayer AG
15.2.7. REGENXBIO Inc.
15.2.8. Aerie Pharmaceutical Inc
15.2.9. Regeneron Pharmaceuticals Inc.
15.2.10. Opthea
16. Research Methodology
17. Key Assumptions and Acronyms

Frequently Asked Questions

2021 is the base year and 2028 is the forecast year.

The report covers the five regions and 15+ countries market data: North America (United States, Canada), Europe (Germany, France, Italy, Spain, and United Kingdom (UK), Asia Pacific (China, India, Japan, Australia & New Zealand), Latin America (Brazil, Mexico, Argentina) and Middle East and Africa (Saudi Arabia, United Arab Emirates, South Africa).

In our report, we provide 12-15 market players’ information into the report. However, based on the client’s request we will provide additional country and regional market players information as well.


Report

Company Profile

  • Thermo Fisher Scientific, Inc. (US)
  • Abcam plc (UK)
  • Bio-Rad Laboratories, Inc. (US)
  • PerkinElmer Inc. (US)
  • Merck KGaA (Germany)
  • Werfen Company (Spain)
  • Cell Signaling Technology, Inc. (US)
  • MEDIPAN GmbH (Germany)
  • Sino Biological, Inc. (China)
  • Danaher Corporation (US)
  • Maravai LifeSciences (US)
  • Enzo Biochem, Inc. (US)

Description

1. Executive Summary
2. Global Macular Degeneration Treatment Market Introduction
2.1. Global Macular Degeneration Treatment Market – Taxonomy
2.2. Global Macular Degeneration Treatment Market –Definitions
2.2.1. By Type
2.2.2. By Stage of Disease
2.2.3. By Route of Administration
2.2.4. By Distribution Channel
2.2.5. By Region
3. Global Macular Degeneration Treatment Market Dynamics
3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Trends
3.5. Global Macular Degeneration Treatment Market Dynamic Factors – Impact Analysis
3.6. Global Macular Degeneration Treatment Market – Competition Landscape
4. Global Macular Degeneration Treatment Market Analysis, 2017-2021 and Forecast, 2022-2028
4.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
4.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
4.3. Market Opportunity Analysis
5. Global Macular Degeneration Treatment Market, By Type, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
5.1. Wet AMD
5.1.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
5.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.1.3. Market Opportunity Analysis
5.2. Dry AMD
5.2.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
5.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.2.3. Market Opportunity Analysis
6. Global Macular Degeneration Treatment Market, By Stage of Disease, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
6.1. Early-stage AMD
6.1.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
6.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.1.3. Market Opportunity Analysis
6.2. Intermediate AMD
6.2.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
6.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.2.3. Market Opportunity Analysis
6.3. Late-stage AMD
6.3.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
6.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.3.3. Market Opportunity Analysis
7. Global Macular Degeneration Treatment Market, By Route of Administration, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
7.1. Intravenous Route
7.1.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
7.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.1.3. Market Opportunity Analysis
7.2. Intravitreal Route
7.2.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
7.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.2.3. Market Opportunity Analysis
8. Global Macular Degeneration Treatment Market, By Distribution Channel, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
8.1. Hospitals
8.1.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
8.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.1.3. Market Opportunity Analysis
8.2. Ophthalmic Clinics
8.2.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
8.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.2.3. Market Opportunity Analysis
8.3. Ambulatory Surgical Centers
8.3.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
8.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.3.3. Market Opportunity Analysis
9. Global Macular Degeneration Treatment Market Forecast, By Region, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
9.1. North America
9.1.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
9.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
9.1.3. Market Opportunity Analysis
9.2. Europe
9.2.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
9.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
9.2.3. Market Opportunity Analysis
9.3. Asia-Pacific
9.3.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
9.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
9.3.3. Market Opportunity Analysis
9.4. Latin America
9.4.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
9.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
9.4.3. Market Opportunity Analysis
9.5. Middle East and Africa
9.5.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
9.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
9.5.3. Market Opportunity Analysis
9.6. Global Macular Degeneration Treatment Market – Opportunity Analysis Index, By Type, By Stage of Disease, By Route of Administration, By Distribution Channel, and Region, 2022-2028
10. North America Macular Degeneration Treatment Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
10.1. Type Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
10.1.1. Wet AMD
10.1.2. Dry AMD
10.2. Stage of Disease Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
10.2.1. Early-stage AMD
10.2.2. Intermediate AMD
10.2.3. Late-stage AMD
10.3. Route of Administration Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
10.3.1. Intravenous Route
10.3.2. Intravitreal Route
10.4. Distribution Channel Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
10.4.1. Hospitals
10.4.2. Ophthalmic Clinics
10.4.3. Ambulatory Surgical Centers
10.5. Country Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
10.5.1. USA
10.5.2. Canada
10.6. North America Macular Degeneration Treatment Market – Opportunity Analysis Index, By Type, By Stage of Disease, By Route of Administration, By Distribution Channel, and Country, 2022-2028
10.7. North America Macular Degeneration Treatment Market Dynamics – Trends
11. Europe Macular Degeneration Treatment Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
11.1. Type Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
11.1.1. Wet AMD
11.1.2. Dry AMD
11.2. Stage of Disease Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
11.2.1. Early-stage AMD
11.2.2. Intermediate AMD
11.2.3. Late-stage AMD
11.3. Route of Administration Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
11.3.1. Intravenous Route
11.3.2. Intravitreal Route
11.4. Distribution Channel Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
11.4.1. Hospitals
11.4.2. Ophthalmic Clinics
11.4.3. Ambulatory Surgical Centers
11.5. Country Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
11.5.1. Germany
11.5.2. UK
11.5.3. France
11.5.4. Spain
11.5.5. Italy
11.5.6. Russia
11.5.7. Rest of Europe
11.6. Europe Macular Degeneration Treatment Market – Opportunity Analysis Index, By Type, By Stage of Disease, By Route of Administration, By Distribution Channel, and Country, 2022-2028
11.7. Europe Macular Degeneration Treatment Market Dynamics – Trends
12. Asia-Pacific Macular Degeneration Treatment Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
12.1. Type Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
12.1.1. Wet AMD
12.1.2. Dry AMD
12.2. Stage of Disease Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
12.2.1. Early-stage AMD
12.2.2. Intermediate AMD
12.2.3. Late-stage AMD
12.3. Route of Administration Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
12.3.1. Intravenous Route
12.3.2. Intravitreal Route
12.4. Distribution Channel Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
12.4.1. Hospitals
12.4.2. Ophthalmic Clinics
12.4.3. Ambulatory Surgical Centers
12.5. Country Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
12.5.1. China
12.5.2. India
12.5.3. Japan
12.5.4. ASEAN
12.5.5. Australia & New Zealand
12.5.6. Rest of Asia-Pacific
12.6. Asia-Pacific Macular Degeneration Treatment Market – Opportunity Analysis Index, By Type, By Stage of Disease, by Drug Class, By Distribution Channel, and Country, 2022-2028
12.7. Asia-Pacific Macular Degeneration Treatment Market Dynamics – Trends
13. Latin America Macular Degeneration Treatment Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
13.1. Type Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
13.1.1. Wet AMD
13.1.2. Dry AMD
13.2. Stage of Disease Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
13.2.1. Early-stage AMD
13.2.2. Intermediate AMD
13.2.3. Late-stage AMD
13.3. Route of Administration Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
13.3.1. Intravenous Route
13.3.2. Intravitreal Route
13.4. Distribution Channel Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
13.4.1. Hospitals
13.4.2. Ophthalmic Clinics
13.4.3. Ambulatory Surgical Centers
13.5. Country Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
13.5.1. Brazil
13.5.2. Mexico
13.5.3. Rest of Latin America
13.6. Latin America Macular Degeneration Treatment Market – Opportunity Analysis Index, By Type, By Stage of Disease, By Route of Administration, By Distribution Channel, and Country, 2022-2028
13.7. Latin America Macular Degeneration Treatment Market Dynamics – Trends
14. Middle East and Africa Macular Degeneration Treatment Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
14.1. Type Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
14.1.1. Wet AMD
14.1.2. Dry AMD
14.2. Stage of Disease Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
14.2.1. Early-stage AMD
14.2.2. Intermediate AMD
14.2.3. Late-stage AMD
14.3. Route of Administration Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
14.3.1. Intravenous Route
14.3.2. Intravitreal Route
14.4. Distribution Channel Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
14.4.1. Hospitals
14.4.2. Ophthalmic Clinics
14.4.3. Ambulatory Surgical Centers
14.5. Country Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
14.5.1. Gulf CoDistribution Channel  Council (GCC) Countries
14.5.2. South Africa
14.5.3. Rest of MEA
14.6. MEA Macular Degeneration Treatment Market – Opportunity Analysis Index, By Type, By Stage of Disease, By Route of Administration, By Distribution Channel, and Country, 2022-2028
14.7. MEA Macular Degeneration Treatment Market Dynamics – Trends
15. Competition Landscape 
15.1. Strategic Dashboard of Top Market Players
15.2. Company Profiles (Introduction, Financial Analysis, Key Products, Key Developments, Strategies, and SWOT Analysis)
15.2.1. Hoffmann-La Roche Ltd
15.2.2. Novartis AG
15.2.3. Pfizer
15.2.4. Kanghong Pharma
15.2.5. Bausch Health Companies Inc.
15.2.6. Bayer AG
15.2.7. REGENXBIO Inc.
15.2.8. Aerie Pharmaceutical Inc
15.2.9. Regeneron Pharmaceuticals Inc.
15.2.10. Opthea
16. Research Methodology
17. Key Assumptions and Acronyms

ASIA PACIFIC OFFICE

Precision Business Insights, MIG 366, SAI PLAZA, 1st Floor, KPHB Colony, Hyderabad - 500072

EUROPE OFFICE

Precision Business Insights, Kemp House, 152 – 160 City Road, London EC1V 2NX